Xenon Pharma

Forecast & Rating20 analysts currently cover Xenon Pharma, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $81.30, about 31.3% upside from the current price of $61.93. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 51.5% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Xenon Pharma closely still see room for the stock to rise. Data as of Aug 26, 2026; for reference only and not investment advice.